Development of lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics. Collaboration with partners to accelerate drug development from preclinical to commercialization.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Acuitas Therapeutics's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: October 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Allozymes
B
Development of integrated enzyme solutions for manufacturing complex oligonucleotide therapeutics, using a proprietary platform combining microfluidics, bioinformatics, and advanced enzyme engineering.
BioSpring
B
Manufacturing and analysis of nucleic acids (mRNA, siRNA, guide RNA, ASO, and other oligonucleotides) for therapeutic use, supporting clinical and commercial drug development programs.
Superbranche
B
Development and production of magnetic nanoparticles for in vivo tracking of innovative therapy drugs and therapeutic applications in oncology.
Initiatives identified among leaders
Réduction et recyclage systématiques des déchets industriels
“BioSpring suit une politique de gestion des déchet...” - BioSpringRéduction déchets plastiques et biologiques via microfluidique en R&D
“Allozymes réduit l'impact environnemental de ses a...” - AllozymesFormation et implication des employés pour la prévention des risques HSE et amélioration continue.
“BioSpring met en place une communication transpare...” - BioSpring40% of similar organizations communicate on CSR issues
+160 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports